XORTX Therapeutics XRTX
NASDAQ XRTX
$1.72 -0.01 (-0.57%)
As of: Oct 2, 2026 · 3:20 PM EDT

XORTX Therapeutics (XRTX) Price to FCF (2023)

Updated

XORTX Therapeutics' (XRTX) Price to FCF came in at 1071.06 for the quarter ended Dec 31, 2023.

Analysis

XORTX Therapeutics (XRTX) Price to FCF (2023) Analysis & Trends

For the year ended Dec 31, 2021, XORTX Therapeutics' Price to FCF stood at 37.56.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 XORTX Therapeutics 1.60 Mn -1.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 1,071.06
API Access

XORTX Therapeutics Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=XRTX&period=max&api_key=YOUR_API_KEY